News for Mineralys Therapeutics Inc Stock (MLYS)

Mineralys Therapeutics, Inc. (MLYS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Accesswire • 09/23/24

MLYS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Mineralys Therapeutics, Inc. and Encourages Investors to Contact the Firm!

GlobeNewsWire • 09/22/24

The Schall Law Firm Seeks Investor Participation In An Inquiry Into Mineralys Therapeutics Inc For Violating Securities Laws

Accesswire • 09/22/24

Bronstein, Gewirtz & Grossman, LLC Encourages Mineralys Therapeutics, Inc. (MLYS) Shareholders to Inquire about Securities Investigation

Accesswire • 09/22/24

Mineralys Therapeutics, Inc. Is Being Investigated By The Schall Law Firm For Securities Fraud And Stakeholders Are Urged To Contribute

Accesswire • 09/21/24

The Schall Law Firm Has Launched An Inquiry Into Mineralys Therapeutics Inc For Violating Securities Laws And Affected Investors Should Reach Out

Accesswire • 09/20/24

Bronstein, Gewirtz & Grossman, LLC Is Investigating Mineralys Therapeutics, Inc. (MLYS) And Encourages Shareholders to Connect

Accesswire • 09/20/24

Mineralys Therapeutics, Inc. Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Shareholders To Take Part

Accesswire • 09/19/24

Bronstein, Gewirtz & Grossman, LLC Encourages Mineralys Therapeutics, Inc. (MLYS) Stockholders to Inquire about Securities Investigation

Accesswire • 09/19/24

Investors Are Invited By The Schall Law Firm To Join An Inquiry Into Mineralys Therapeutics Inc For Securities Law Violations

Accesswire • 09/18/24

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Mineralys Therapeutics, Inc. (MLYS) and Encourages Investors to Learn More About the Investigation

Accesswire • 09/18/24

Mineralys In Hypertension: Upcoming Catalysts And Strong Positioning

Seeking Alpha • 09/17/24

The Schall Law Firm Is Looking Into Mineralys Therapeutics, Inc. For Possible Securities Fraud And Affected Stockholders Should Reach Out

Accesswire • 09/17/24

Mineralys Therapeutics, Inc. (MLYS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Accesswire • 09/17/24

Mineralys Therapeutics Inc May Have Engaged In Securities Law Violations And The Schall Law Firm Urges Investors With Losses To Partake In An Inquiry

Accesswire • 09/16/24

Bronstein, Gewirtz & Grossman, LLC Is Investigating Mineralys Therapeutics, Inc. (MLYS) And Encourages Investors to Connect

Accesswire • 09/16/24

The Schall Law Firm Is Looking Into Mineralys Therapeutics, Inc. For Possible Securities Fraud And Affected Shareholders Should Reach Out

Accesswire • 09/15/24

Mineralys Therapeutics Inc May Have Committed Securities Law Violations And The Schall Law Firm Invites Investor Participation In An Inquiry

Accesswire • 09/14/24

The Schall Law Firm Is Looking Into Mineralys Therapeutics, Inc. For Possible Securities Fraud And Stockholders Should Reach Out

Accesswire • 09/13/24

Mineralys Therapeutics, Inc. (MLYS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Accesswire • 09/13/24

Mineralys Therapeutics Inc May Have Violated Securities Laws And The Schall Law Firm Invites Investors To Join An Inquiry

Accesswire • 09/12/24

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Mineralys Therapeutics, Inc.(MLYS) and Encourages Stockholders to Learn More About the Investigation

Accesswire • 09/12/24

The Schall Law Firm Is Looking Into Whether Mineralys Therapeutics, Inc. Committed Securities Fraud And Affected Shareholders Can Reach Out

Accesswire • 09/11/24

Bronstein, Gewirtz & Grossman, LLC Encourages Mineralys Therapeutics, Inc.(MLYS) Investors to Inquire about Securities Investigation

Accesswire • 09/11/24

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Mineralys Therapeutics, Inc.(MLYS) And Encourages Investors to Reach Out

Accesswire • 09/10/24